Importantly, ITGAM and ITGB2 may emerge as promising therapeutic targets for mitigating sepsis-induced ALI, while microbiota-based interventions such as FMT offer translational potential as adjunctive therapeutic strategies. This evidence concerns the gene ITGB2 and acute respiratory distress syndrome.